Every year, Nigeria commits more than a billion dollars to malaria control—funding medicines, insecticide-treated nets, diagnostics, and mass public health campaigns. Yet the disease remains stubbornly widespread. For experts at the Nigerian Institute of Medical Research (NIMR), this is not evidence of failed science, but of a complex mix of biology, environment, behaviour, and systemic gaps that continue to undermine progress.
Malaria, they argue, has proven resilient not because solutions do not exist, but because the conditions sustaining transmission are deeply embedded in daily life, infrastructure, and ecology.
The Economic Weight of Malaria
The cost of malaria goes far beyond hospitals and clinics. Nigeria’s Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, has placed the annual economic burden of the disease at between $1.1 billion and $1.6 billion, factoring in healthcare spending and lost productivity. By 2030, he warns, the figure could climb to $2.8 billion if current trends persist.
At the household level, malaria quietly erodes income through repeated out-of-pocket payments for treatment and days lost to illness. At the national level, it weakens workforce productivity and discourages tourism and investment—making malaria not only a health issue, but a development challenge.
The impact is most severe among children, rural dwellers, and low-income workers, where illness often means both medical expenses and missed livelihoods.
Resistance: An Inevitable Biological Battle
According to Dr. Adeola Olukosi, Director of Research and Head of NIMR’s Malaria Research Group, resistance lies at the heart of malaria’s persistence.
“Drug resistance by parasites and insecticide resistance by mosquitoes have been with us for a very long time,” she explained. “We have a limited arsenal, and the pressure we apply will always drive resistance.”
Through partnerships with the National Malaria Elimination Programme (NMEP), NIMR maintains continuous surveillance across parasite and mosquito sentinel sites nationwide. These monitor drug effectiveness, mosquito behaviour, and insecticide susceptibility. Encouragingly, Nigeria’s artemisinin-based combination therapies remain effective, meaning there is no immediate need to revise national treatment guidelines.
However, Olukosi warned that continued use of banned drugs such as chloroquine poses a serious risk. Individual success stories, she said, only help sustain resistant parasites and undermine collective gains.
New Tools, Smarter Deployment
Innovation is beginning to reshape malaria control strategies. Artificial Intelligence (AI), for instance, has been deployed during large-scale campaigns such as those in Kaduna State. AI systems helped guide evidence-based interventions, track implementation in real time, and flag gaps instantly.
“AI helps us see what has been done, where it has been done, and what still needs to be done,” Olukosi said. While still at an early stage of adoption, the technology is already improving efficiency and accountability.
Mosquitoes, Environment, and Urban Threats
Nigeria’s malaria challenge is further complicated by the diversity of its mosquito vectors. Different species dominate different regions—and sometimes even coexist within the same community—responding unevenly to control measures.
Recent surveillance has confirmed the presence of Anopheles stephensi, an invasive species from Southeast Asia. Unlike traditional rural vectors, it thrives in urban environments and shows resistance to multiple insecticides, posing a new and worrying threat as Nigerian cities expand.
Environmental factors also remain firmly in malaria’s favour. Warm temperatures, seasonal rainfall, dense vegetation, and abundant breeding sites create ideal transmission conditions year-round. Even human genetics play a role: traits like sickle cell offer partial protection but allow both parasite and gene to persist over generations.
Funding, Ownership, and Community Trust
Despite growing political commitment, malaria research in Nigeria still depends heavily on external funding. Olukosi stressed the need for stronger domestic ownership—not only of programmes, but of research priorities and tool development.
“We do not do research for research sake,” she said. “We go back to communities, explain what we found, and share what can help them.”
Ethical engagement and trust-building, she noted, are essential if interventions are to be accepted and sustained.
Beyond the Numbers: Understanding Nigeria’s Reality
Professor John Oladapo Obafunwa, Director General of NIMR, cautioned against simplistic interpretations of Nigeria’s malaria statistics.
“Nigeria represents a significant proportion of Africa’s population, so absolute numbers will always appear high,” he said. “That does not mean we do not have a serious problem—but comparisons must be contextual.”
He pointed out that malaria trends in Lagos, for example, cannot be directly compared with those in Europe or North America due to differences in climate, housing, infrastructure, and population movement. Migration, trade, worship, and travel all allow malaria to cross borders easily.
Social and behavioural factors also play a major role. Poverty delays care-seeking, gender dynamics limit access to treatment, and misdiagnosis remains common. “Not every fever is malaria,” Obafunwa stressed, noting that years of presumptive treatment have distorted disease data and allowed other illnesses to worsen untreated.
Progress Is Possible, but Not Automatic
Some gains are undeniable. Lagos State, for instance, has reported malaria prevalence as low as two per cent. According to Obafunwa, this shows that suppression—keeping malaria very low and controlled—is achievable.
Still, gaps persist. Millions of insecticide-treated nets are distributed, yet many go unused. Power outages, poor housing, self-medication, delayed diagnosis, and reliance on unverified treatments all sustain transmission and fuel resistance.
Overdiagnosis remains another concern. “For years, every fever was called malaria,” Obafunwa said. “If you do not test properly, you treat wrongly, and the real disease progresses.”
No Silver Bullet, Only Shared Responsibility
Experts agree that malaria control demands integrated solutions: better housing, environmental sanitation, larval source management, accurate diagnosis, and targeted protection for high-risk groups. None of these can succeed in isolation.
“We cannot outsource our health security,” Obafunwa warned. Without domestic leadership, Nigeria risks remaining reactive rather than proactive in the global malaria fight.
There is no single cure-all. Progress depends on smarter deployment of existing tools, continuous surveillance, behavioural change, and collective responsibility.
As NIMR’s leadership emphasises, malaria is not just a medical problem—it is social, economic, environmental, and behavioural. Until these dimensions are tackled together, the disease will continue to find space to survive.
For Nigeria, the battle against malaria does not end in laboratories or hospitals. It begins in homes, communities, policies, and everyday choices.